Thoughts and questions arising upon the recognition of the broadly bioactive and very well tolerated antiseptic N-chlorotaurine as a highly useful medicant for prophylaxis and therapy

Бесплатный доступ

This report emerged from the experiences and observations of the authors who explored fundamental features of NCT and accounted for production and essential understanding of its realm of welcome properties. N-chlorotaurine (NCT) is an endogenous mild active chlorine compound, which can be synthesized chemically and applied topically as an effective anti- infective and antiseptic to different body sites. Naturally, it is produced by activated human granulocytes and monocytes during the oxidative burst. Besides the typical broad-spectrum microbicidal activity of chloramines against all kinds of microorganisms, it has anti-inflammatory properties and is involved in termination of inflammation. Because of its high tolerability and absence of systemic adverse effects due to decay to ubiquitous taurine and chloride, it can be used in sensitive body regions, too, for instance the eye, body cavities and lower airways. The latter renders NCT inhalation a promising means for the prevention and treatment of viral pneumonia including SARS-CoV-2 (Covid-19), chronic bronchitis, and cystic fibrosis. Further clinical development is urgently needed to characterize the preventive and therapeutic effects in detail. Particularly the time of the present pandemic confirmed how difficult recognition and support of innovations frequently is.

Еще

N-chlorotaurine, antiseptic, anti-infective, Covid-19, nose spray, mouthwash, inhalation, tolerability, prophylaxis, public health

Короткий адрес: https://sciup.org/143173977

IDR: 143173977

Список литературы Thoughts and questions arising upon the recognition of the broadly bioactive and very well tolerated antiseptic N-chlorotaurine as a highly useful medicant for prophylaxis and therapy

  • Stelmaszynska T. and Zgliczynski J.M. Myeloperoxidase of human neutrophilic granulocytes as chlorinating enzyme. Eur. J. Biochem. 1974; 45: 305–312.
  • Zgliczynski J.M., Stelmaszynska T., Domanski J. and Ostrowski W. Chloramines as intermediates of oxidation reaction of amino acids by myeloperoxidase. Biochim. Biophys. Acta. 1971; 235: 419–424.
  • Weiss S.J., Lampert M.B. and Test S.T. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science. 1983; 222: 625–628.
  • Allred A.L. Electronegativity values from thermochemical data. J. Inorg. Nucl. Chem. 1961; 17: 215-221. doi: 10.1016/0022-1902(61)80142-5.
  • Gottardi W., Debabov D. and Nagl M. N-chloramines: a promising class of well-tolerated topical antiinfectives. Antimicrob. Agents Chemother. 2013; 57: 1107–1114.
  • Gottardi W. and Nagl M. N-chlorotaurine, a natural antiseptic with outstanding tolerability. J. Antimicrob. Chemother. 2010; 65: 399–409.
  • Gottardi W. and Nagl M. Active halogen compounds and proteinaceous material: loss of activity of topical antiinfectives by halogen consumption. J. Pharm. Pharmacol. 2013; 65: 213–218. 10.1111/j.2042-7158.2012.01589.x
  • Gottardi W. and Nagl M. Less is more, transferring a principle from art to science. Curr. Trends Microbiol. 2019; 13: 47–54.
  • Gottardi W. and Nagl M. N-chlorotaurine: Random biochemical drug or evolution tailored masterpiece? Curr. Trends Microbiol. 2021; 15: in press.
  • Scudamore C. An account of cases of consumption treated by iodine inhalation, with the iodine formula. The Lancet. 1831; 16: 189–191. https://doi.org/10.1016/S0140-6736(02)73613-1.
  • Dakin H.D. The behaviour of hypochlorites on intravenous injection and their action on blood serum. BMJ. 1916; 1: 852–854.
  • Grisham M.B., Jefferson M.M., Melton D.F., Thomas E.L. Chlorination of endogenous amines by isolated neutrophils. J. Biol. Chem. 1984; 259: 10404–10413.
  • Nagl M,, Arnitz R., Lackner M. N-chlorotaurine, a promising future candidate for topical therapy of fungal infections. Mycopathologia. 2018; 183: 161–170. 10.1007/s11046-017-0175-z.
  • Ari A. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respiratory medicine. 2020; 167: 105987. 10.1016/j.rmed.2020.105987.
  • Carrouel F., Gon alves L.S., Conte M.P., Campus G., Fisher J., Fraticelli L., Gadea-Deschamps E., Ottolenghi L. and Bourgeois D. Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2. Journal of dental research. 2021; 100: 124-132. 10.1177/0022034520967933.
  • Cegolon L., Javanbakht M., Mastrangelo G. Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents. International journal of hygiene and environmental health. 2020; 230: 113605. 10.1016/j.ijheh.2020.113605.
  • Kofler W., Glazachev O.S., Lyshol H.,Tellnes G. Is fighting against COVID-19 enough? Scand. J. Public Health. 2020; 49: 9–13. 10.1177/1403494820969539.
  • Lackner M., Rössler A., Volland A. et al. N-chlorotaurine, a novel inhaled virucidal antiseptic is highly active against respiratory viruses including SARS-CoV-2 (COVID-19). Res. Square. 2020; https://www.researchsquare.com/article/rs-118665/v1: 10.21203/rs.3.rs-118665/v1.
  • Mitchell J.P., Berlinski A., Canisius S. et al. Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group. Journal of aerosol medicine and pulmonary drug delivery. 2020; 33: 235–238. 10.1089/jamp.2020.1622.
  • Figueroa J.M. et al. and Group C-C. Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease. medRxiv preprint. 2021; 2021: 10.1101/ 2021.04.13.21255409.
  • Wang L., Khosrovi B., Najafi R. N-Chloro-2,2-dimethyltaurines: a new class of remarkably stable N-chlorotaurines. Tetrahedron Lett. 2008; 49: 2193–2195.
  • Low E., Kim B., Francavilla C. et al. Structure stability/activity relationships of sulfone stabilized N,N-dichloroamines. Bioorg. Med. Chem. Lett. 2011; 21: 3682–3685.
  • Low E., Nair S., Shiau T. et al. N,N-Dichloroaminosulfonic acids as novel topical antimicrobial agents. Bioorg. Med. Chem. Lett. 2009; 19: 196–198.
  • Baliou S., Kyriakopoulos A.M., Spandidos D.A., Zoumpourlis V. Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review). International journal of oncology. 2020; 57: 631–664. 10.3892/ijo.2020.5100.
  • Marcinkiewicz J. and Kontny E. Taurine and inflammatory diseases. Amino Acids. 2014; 46: 7–20. 10.1007/s00726-012-1361-4.
  • Anich C., Orth-Höller D., Lackner M., Nagl M. Microbicidal activity of N-chlorotaurine against multiresistant nosocomial bacteria. J. Appl. Microbiol. 2021; DOI: 10.1111/jam.15052. DOI: 10.1111/jam.15052.
  • Dudani A.K., Martyres A., Fliss H. Short communication: rapid preparation of preventive and therapeutic whole-killed retroviral vaccines using the microbicide taurine chloramine. AIDS Res. Hum. Retroviruses. 2008; 24: 635–642.
  • Garcia L.A.T., Boff L., Barardi C.R.M., Nagl M. Inactivation of adenovirus in water by natural and synthetic compounds Food and Environmental Virology. 2019; 11: 157–166. 10.1007/s12560-019-09370-8.
  • Huemer H.P., Nagl M., Irschick E.U. In vitro prevention of vaccinia and herpes virus infection spread in explanted human corneas by N-chlorotaurine. Ophthalmic. Res. 2010; 43: 145–152.
  • Kyriakopoulos A.M., Logotheti S., Marcinkiewicz J., Nagl M. N-chlorotaurine and N-bromotaurine combination regimen for the cure of valacyclovir-unresponsive herpes zoster comorbidity in a multiple sclerosis patient. International Journal of Medical and Pharmaceutical Case Reports. 2016; 7: 1–6. 10.9734/IJMPCR/2016/25476.
  • Nagl M., Larcher C., Gottardi W. Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Res. 1998; 38: 25–30.
  • Romanowski E.G., Yates K.A., Teuchner B. et al. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Invest. Ophthalmol. Vis. Sci. 2006; 47: 2021–2026.
  • Teuchner B., Nagl M., Schidlbauer A. et al. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis — a double-blind randomized phase 2 clinical trial. J. Ocul. Pharmacol. Ther. 2005; 21: 157–165.
  • Lackner M., Binder U., Reindl M. et al. N-chlorotaurine exhibits fungicidal activity against therapy-refractory Scedosporium species and Lomentospora prolificans. Antimicrob. Agents Chemother. 2015; 59: 6454–6462. 10.1128/AAC.00957-15.
  • Almehdi A.M., Khoder G., Alchakee A.S. et al. SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies. Infection. 2021; 10.1007/s15010-021-01677-8.
  • Kramer A. and Eggers M. Prevention of respiratory viral infections by virucidal mucosal antisepsis among medical staff and in the community. Hyg. Med. 2020; 45: D118-D126.
  • Kofler W. and Nagl M. The whole strategy has to be extended now — beyond modeling. Science eletters. 2020; 370: 1015.
  • Arnitz R., Stein M., Bauer P. et al. Tolerability of inhaled N-chlorotaurine in humans — a double-blind randomized phase I clinical study. Ther. Adv. Resp. Dis. 2018; 12: 1-14. 10.1177/1753466618778955.
  • Righetti P.G. and Bossi A. Isoelectric focusing in immobilized pH gradients: recent analytical and preparative developments. Anal. Biochem. 1997; 247: 1–10.
Еще
Статья